Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Navrogen's investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, National Cancer Institute, Tellus BioVentures.
Navrogen is headquartered in Philadelphia, United States.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Navrogen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Navrogen — Funding & Investors." VCBacked, September 8, 2025, https://www.vcbacked.co/company/navrogen. Accessed November 11, 2026.
VCBacked. (2025). Navrogen — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/navrogen
{{cite web |title=Navrogen — Funding & Investors |url=https://www.vcbacked.co/company/navrogen |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Navrogen? Request a listing update